Sophisticated analytical technologies are complementing traditional approaches in the identification of residual process-related impurities of biotherapeutics.
Stuart Pengelley
Advertisement
Stuart Pengelley is the senior scientist, Biopharma Application Development for Bruker Daltonics.
Articles by Stuart Pengelley
Advertisement
Latest Updated Articles
Increasing the Depth and Reliability of HCP Analysis Using TIMS-MSPublished: July 15th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
